First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations
Resource Type
Article
Authors
Janku, Filip ; Kim, Tae Min ; Iyer, Gopakumar ; Spreafico, Anna ; Elez, Elena ; de Jonge, Maja ; Yamamoto, Noboru ; van der Wekken, Anthonie J. ; Ascierto, Paolo Antonio ; Maur, Michela ; Marmé, Frederik ; Kiladjian, Jean-Jacques ; Basu, Sumit ; Baffert, Fabienne ; Buigues, Amparo ; Chen, Chi ; Cooke, Vesselina ; Giorgetti, Elisa ; Kim, Jaeyeon ; McCarthy, Fiona ; Moschetta, Michele ; Dummer, Reinhard
Source
In European Journal of Cancer January 2024 196
Subject
DD
Language
ISSN
0959-8049